TRexBio Prices IPO at $14 Per Share, Expects $116.7 Million
TRexBio priced 8,333,334 shares at $14 each, with gross proceeds expected to be approximately $116.7 million. Trading is expected to begin on Nasdaq on Oct. 9; the offering is expected to close on Oct. 13, subject to customary conditions.